Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Naples
Clinical trial register · Italy

Clinical Trials in Naples, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 50 Naples 37 Roma 24 Pisa 17 Florence 17
Narrow the registerReset
Recruitment status
Phase
Site location
Milan50 Naples37 Roma24 Pisa17 Florence17
All 69 locations
Target enrolment
to

Trials with a site in Naples

37 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Bristol-Myers Squibb
Phase 3
850
Naples, Ravenna, Aviano, Orbassano, Rome, Milan, Parma
2026-03-16
Recruiting
Bristol-Myers Squibb
Phase 2/3
690
Naples, Turin, Padova, Milan, Roma
2026-03-13
Recruiting
Bristol-Myers Squibb
Phase 3
750
Ferrara (Cona), Aviano, Catania, Candiolo, Genova, Milan, Naples, Novara
2026-03-12
Recruiting
Bristol-Myers Squibb
Phase 2/3
590
Naples, Ravenna, Aviano, Orbassano, Siena, Perugia, Bologna, Milan
2026-01-02
Recruiting
Bristol-Myers Squibb
Phase 3
650
Naples, Rome, Milan, Pisa, Brescia, Isernia, Roma
2025-12-02
Recruiting
Bristol-Myers Squibb
Phase 2/3
500
Ravenna, Aviano, Orbassano, Candiolo, Avellino, Milan, Naples, Parma
2025-11-05
Recruiting
Bristol-Myers Squibb
Phase 2/3
470
Bari, Genoa, Rome, Pisa, Castelfranco Veneto, Milan, Naples, Parma
2025-09-30
Recruiting
Bristol-Myers Squibb
Phase 3
3,040
L’Aquila, Cagliari, Rozzano, Baggiovara, Bologna, Chieti, Naples, Roma
2025-09-22
Recruiting
Bristol-Myers Squibb
Phase 3
586
Naples, Foggia, Roma
2025-07-21
Recruiting
Bristol-Myers Squibb
Phase 3
426
Naples, Rome, Milan, Pisa, Brescia, Isernia, Roma
2025-07-16
Recruiting
Bristol-Myers Squibb
Phase 3
194
Naples, Milan, Rome
2025-04-08
Recruiting
Bristol-Myers Squibb
Phase 3
60
Naples, Florence
2025-03-13
Recruiting
Bristol-Myers Squibb
Phase 3
1,000
Bari, Ravenna, Monza, Milan, Naples, Rome, Peschiera del Garda, Bergamo
2024-10-07
Active, closed
Bristol-Myers Squibb
Phase 3
44
Florence, Genova, Naples
2024-04-17
Active, closed
Bristol-Myers Squibb
Phase 3
190
Aviano, Milan, Monza, Naples, Rome
2023-12-21
Active, closed
Bristol-Myers Squibb
Phase 2
227
Naples, San Donato Milanese, Pisa, Bergamo
2023-11-07
Active, closed
Bristol-Myers Squibb
Phase 2
100
Bergamo, Meldola, Milan, Padova, Roma, Torino, Naples
2023-11-06
Active, closed
Bristol-Myers Squibb
Observational
404
Naples
2023-10-11
Active, closed
Bristol-Myers Squibb
Phase 3
106
Reggio Calabria, Naples, Rome, Pavia, Rozzano (MI), Novara, Turin, Florence
2023-10-05
Active, closed
Bristol-Myers Squibb
Phase 3
774
Brescia, Milan, Naples, Pisa, Rome, Udine
2023-09-11
Active, closed
Bristol-Myers Squibb
Phase 3
1,230
Catania, Florence, Genova, Milan, Pisa, Roma, Torino, Naples
2023-06-22
Active, closed
Bristol-Myers Squibb
Phase 3
579
Genova, Siena, Bari, Milan, Naples, Perugia, Roma
2023-03-06
Active, closed
Bristol-Myers Squibb
Phase 3
516
Rome, Milan, Pisa, Padova, Brescia, Naples, Verona
2023-01-12
Recruiting
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
NCT04895709Cervical Cancer, Gastric/Gastroesophageal Junction Adenocarcinoma, Microsatellite Stable Colorectal Cancer, Non-Small-Cell Lung Cancer
Bristol-Myers Squibb
Phase 1/2
1,109
Rozzano, Candiolo, Milan, Naples, Roma, Siena
2021-05-27
Active, closed
Bristol-Myers Squibb
Phase 3
790
Palermo, Bergamo, Milan, Naples, Padova, Perugia, Siena
2019-10-28
Active, closed
Bristol-Myers Squibb
Phase 3
545
Messina, Bologna, Florence, Meldola, Milan, Modena, Monserrato, Naples
2018-04-18
Active, closed
Bristol-Myers Squibb
Phase 2/3
714
Turin, Bergamo, Milan, Naples, Padova, Siena
2018-04-11
Active, closed
Bristol-Myers Squibb
Observational
800
Florence, Genova, Naples, Padova, Trento
2013-01-30
Active, closed
Bristol-Myers Squibb
Observational
2,555
Pesaro, Ancona, Cagliari, Florence, Lecce, Messina, Milan, Naples
2012-06-13
Rows per page Showing 1–37 of 37
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 8 October 2026. https://priyalifescience.com/clinical-trials-italy/city/naples

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 37 of those studies with a site in Naples that also match the filters currently applied.

How many clinical trials are recruiting in Naples?

18 of the 37 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 19 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Naples), 37 studies
PhaseStudiesRecruitingShare
Phase 3211056.8%
Phase 2/37518.9%
Phase 25213.5%
Observational308.1%
Phase 1/2112.7%

Most active sponsors

Lead sponsors with the most studies (Naples)
Lead sponsorStudiesRecruiting
Bristol-Myers Squibb3718
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.